APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bifidobacterium Animalis

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bifidobacterium Animalis Industry Growth and Trends Forecast to 2032

Report ID 173231770124 December 2025109 pages

Choose your research edition.

Industry ResearchBifidobacterium Animalis Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Bifidobacterium Animalis Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Bifidobacterium Animalis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bifidobacterium Animalis Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Bifidobacterium Animalis Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Bifidobacterium Animalis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bifidobacterium Animalis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bifidobacterium Animalis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bifidobacterium Animalis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bifidobacterium Animalis include ADM, ATCC, Chr. Hansen, Creative Biolabs, DuPont Nutrition & Biosciences, Fengchen Group, Microbiologics, Morinaga and SynBalance, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bifidobacterium Animalis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bifidobacterium Animalis market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bifidobacterium Animalis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bifidobacterium Animalis.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bifidobacterium Animalis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bifidobacterium Animalis Market by Company

ADM

ATCC

Chr. Hansen

Creative Biolabs

DuPont Nutrition & Biosciences

Fengchen Group

Microbiologics

Morinaga

SynBalance

BGI Nutri

Wecare Probiotics

Yili Group

Wisbiom (Beijing) Biotechnology

Bifidobacterium Animalis Segment by Type

Bifidobacterium Animalis Subsp. Lactis

Bifidobacterium Animalis Subsp.

Bifidobacterium Animalis Segment by Application

Medicine and Health Products

Food

Clinical Auxiliary Treatment

Animal Feed

Other

Bifidobacterium Animalis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifidobacterium Animalis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bifidobacterium Animalis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifidobacterium Animalis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bifidobacterium Animalis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bifidobacterium Animalis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Bifidobacterium Animalis Subsp. Lactis Table 2. Major Company of Bifidobacterium Animalis Subsp. Table 3. Global Bifidobacterium Animalis Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Bifidobacterium Animalis Sales by Type (2021-2026) & (t) Table 5. Global Bifidobacterium Animalis Sales Market Share in Volume by Type (2021-2026) Table 6. Global Bifidobacterium Animalis Sales by Type (2021-2026) & (US$ Million) Table 7. Global Bifidobacterium Animalis Sales Market Share in Value by Type (2021-2026) Table 8. Global Bifidobacterium Animalis Price by Type (2021-2026) & (USD/t) Table 9. Global Bifidobacterium Animalis Sales by Type (2027-2032) & (t) Table 10. Global Bifidobacterium Animalis Sales Market Share in Volume by Type (2027-2032) Table 11. Global Bifidobacterium Animalis Sales by Type (2027-2032) & (US$ Million) Table 12. Global Bifidobacterium Animalis Sales Market Share in Value by Type (2027-2032) Table 13. Global Bifidobacterium Animalis Price by Type (2027-2032) & (USD/t) Table 14. North America Bifidobacterium Animalis Sales by Type (2021-2026) & (t) Table 15. North America Bifidobacterium Animalis Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Bifidobacterium Animalis Sales by Type (2021-2026) & (t) Table 17. Europe Bifidobacterium Animalis Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Bifidobacterium Animalis Sales by Type (2021-2026) & (t) Table 19. Asia-Pacific Bifidobacterium Animalis Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Bifidobacterium Animalis Sales by Type (2021-2026) & (t) Table 21. Latin America Bifidobacterium Animalis Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Bifidobacterium Animalis Sales by Type (2021-2026) & (t) Table 23. Middle East and Africa Bifidobacterium Animalis Sales by Type (2021-2026) & (US$ Million) Table 24. Bifidobacterium Animalis Industry Trends Table 25. Bifidobacterium Animalis Industry Drivers Table 26. Bifidobacterium Animalis Industry Opportunities and Challenges Table 27. Bifidobacterium Animalis Industry Restraints Table 28. Global Bifidobacterium Animalis Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Bifidobacterium Animalis Revenue Market Share by Company (2021-2026) Table 30. Global Bifidobacterium Animalis Sales by Company (2021-2026) & (t) Table 31. Global Bifidobacterium Animalis Sales Share by Company (2021-2026) Table 32. Global Bifidobacterium Animalis Market Price by Company (2021-2026) & (USD/t) Table 33. Global Bifidobacterium Animalis Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Bifidobacterium Animalis Major Company Production Sites and Headquarters Table 35. Global Bifidobacterium Animalis Company, Product Type & Application Table 36. Global Bifidobacterium Animalis Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Bifidobacterium Animalis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Bifidobacterium Animalis Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Bifidobacterium Animalis Sales by Region (2021-2026) & (t) Table 41. Global Bifidobacterium Animalis Sales Market Share in Volume by Region (2021-2026) Table 42. Global Bifidobacterium Animalis Sales by Region (2021-2026) & (US$ Million) Table 43. Global Bifidobacterium Animalis Sales Market Share in Value by Region (2021-2026) Table 44. Global Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 45. Global Bifidobacterium Animalis Sales by Region (2027-2032) & (t) Table 46. Global Bifidobacterium Animalis Sales Market Share in Volume by Region (2027-2032) Table 47. Global Bifidobacterium Animalis Sales by Region (2027-2032) & (US$ Million) Table 48. Global Bifidobacterium Animalis Sales Market Share in Value by Region (2027-2032) Table 49. Global Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 50. Global Bifidobacterium Animalis Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Bifidobacterium Animalis Sales by Application (2021-2026) & (t) Table 52. Global Bifidobacterium Animalis Sales Market Share in Volume by Application (2021-2026) Table 53. Global Bifidobacterium Animalis Sales by Application (2021-2026) & (US$ Million) Table 54. Global Bifidobacterium Animalis Sales Market Share in Value by Application (2021-2026) Table 55. Global Bifidobacterium Animalis Price by Application (2021-2026) & (USD/t) Table 56. Global Bifidobacterium Animalis Sales by Application (2027-2032) & (t) Table 57. Global Bifidobacterium Animalis Sales Market Share in Volume by Application (2027-2032) Table 58. Global Bifidobacterium Animalis Sales by Application (2027-2032) & (US$ Million) Table 59. Global Bifidobacterium Animalis Sales Market Share in Value by Application (2027-2032) Table 60. Global Bifidobacterium Animalis Price by Application (2027-2032) & (USD/t) Table 61. North America Bifidobacterium Animalis Sales by Application (2021-2026) & (t) Table 62. North America Bifidobacterium Animalis Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Bifidobacterium Animalis Sales by Application (2021-2026) & (t) Table 64. Europe Bifidobacterium Animalis Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Bifidobacterium Animalis Sales by Application (2021-2026) & (t) Table 66. Asia-Pacific Bifidobacterium Animalis Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Bifidobacterium Animalis Sales by Application (2021-2026) & (t) Table 68. Latin America Bifidobacterium Animalis Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Bifidobacterium Animalis Sales by Application (2021-2026) & (t) Table 70. Middle East and Africa Bifidobacterium Animalis Sales by Application (2021-2026) & (US$ Million) Table 71. ADM Company Information Table 72. ADM Business Overview Table 73. ADM Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. ADM Bifidobacterium Animalis Product Portfolio Table 75. ADM Recent Development Table 76. ATCC Company Information Table 77. ATCC Business Overview Table 78. ATCC Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. ATCC Bifidobacterium Animalis Product Portfolio Table 80. ATCC Recent Development Table 81. Chr. Hansen Company Information Table 82. Chr. Hansen Business Overview Table 83. Chr. Hansen Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Chr. Hansen Bifidobacterium Animalis Product Portfolio Table 85. Chr. Hansen Recent Development Table 86. Creative Biolabs Company Information Table 87. Creative Biolabs Business Overview Table 88. Creative Biolabs Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Creative Biolabs Bifidobacterium Animalis Product Portfolio Table 90. Creative Biolabs Recent Development Table 91. DuPont Nutrition & Biosciences Company Information Table 92. DuPont Nutrition & Biosciences Business Overview Table 93. DuPont Nutrition & Biosciences Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. DuPont Nutrition & Biosciences Bifidobacterium Animalis Product Portfolio Table 95. DuPont Nutrition & Biosciences Recent Development Table 96. Fengchen Group Company Information Table 97. Fengchen Group Business Overview Table 98. Fengchen Group Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Fengchen Group Bifidobacterium Animalis Product Portfolio Table 100. Fengchen Group Recent Development Table 101. Microbiologics Company Information Table 102. Microbiologics Business Overview Table 103. Microbiologics Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Microbiologics Bifidobacterium Animalis Product Portfolio Table 105. Microbiologics Recent Development Table 106. Morinaga Company Information Table 107. Morinaga Business Overview Table 108. Morinaga Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Morinaga Bifidobacterium Animalis Product Portfolio Table 110. Morinaga Recent Development Table 111. SynBalance Company Information Table 112. SynBalance Business Overview Table 113. SynBalance Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. SynBalance Bifidobacterium Animalis Product Portfolio Table 115. SynBalance Recent Development Table 116. BGI Nutri Company Information Table 117. BGI Nutri Business Overview Table 118. BGI Nutri Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. BGI Nutri Bifidobacterium Animalis Product Portfolio Table 120. BGI Nutri Recent Development Table 121. Wecare Probiotics Company Information Table 122. Wecare Probiotics Business Overview Table 123. Wecare Probiotics Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. Wecare Probiotics Bifidobacterium Animalis Product Portfolio Table 125. Wecare Probiotics Recent Development Table 126. Yili Group Company Information Table 127. Yili Group Business Overview Table 128. Yili Group Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 129. Yili Group Bifidobacterium Animalis Product Portfolio Table 130. Yili Group Recent Development Table 131. Wisbiom (Beijing) Biotechnology Company Information Table 132. Wisbiom (Beijing) Biotechnology Business Overview Table 133. Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 134. Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Product Portfolio Table 135. Wisbiom (Beijing) Biotechnology Recent Development Table 136. North America Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 137. North America Bifidobacterium Animalis Sales by Country (2021-2026) & (t) Table 138. North America Bifidobacterium Animalis Sales Market Share by Country (2021-2026) Table 139. North America Bifidobacterium Animalis Sales Forecast by Country (2027-2032) & (t) Table 140. North America Bifidobacterium Animalis Sales Market Share Forecast by Country (2027-2032) Table 141. North America Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Bifidobacterium Animalis Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Bifidobacterium Animalis Market Share by Country (2021-2026) Table 144. North America Bifidobacterium Animalis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Bifidobacterium Animalis Market Share Forecast by Country (2027-2032) Table 146. Europe Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 147. Europe Bifidobacterium Animalis Sales by Country (2021-2026) & (t) Table 148. Europe Bifidobacterium Animalis Sales Market Share by Country (2021-2026) Table 149. Europe Bifidobacterium Animalis Sales Forecast by Country (2027-2032) & (t) Table 150. Europe Bifidobacterium Animalis Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Bifidobacterium Animalis Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Bifidobacterium Animalis Market Share by Country (2021-2026) Table 154. Europe Bifidobacterium Animalis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Bifidobacterium Animalis Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Bifidobacterium Animalis Sales by Country (2021-2026) & (t) Table 158. Asia-Pacific Bifidobacterium Animalis Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Bifidobacterium Animalis Sales Forecast by Country (2027-2032) & (t) Table 160. Asia-Pacific Bifidobacterium Animalis Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Bifidobacterium Animalis Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Bifidobacterium Animalis Market Share by Country (2021-2026) Table 164. Asia-Pacific Bifidobacterium Animalis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Bifidobacterium Animalis Market Share Forecast by Country (2027-2032) Table 166. Latin America Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 167. Latin America Bifidobacterium Animalis Sales by Country (2021-2026) & (t) Table 168. Latin America Bifidobacterium Animalis Sales Market Share by Country (2021-2026) Table 169. Latin America Bifidobacterium Animalis Sales Forecast by Country (2027-2032) & (t) Table 170. Latin America Bifidobacterium Animalis Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Bifidobacterium Animalis Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Bifidobacterium Animalis Market Share by Country (2021-2026) Table 174. Latin America Bifidobacterium Animalis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Bifidobacterium Animalis Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Bifidobacterium Animalis Sales by Country (2021-2026) & (t) Table 178. Middle East and Africa Bifidobacterium Animalis Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Bifidobacterium Animalis Sales Forecast by Country (2027-2032) & (t) Table 180. Middle East and Africa Bifidobacterium Animalis Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Bifidobacterium Animalis Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Bifidobacterium Animalis Market Share by Country (2021-2026) Table 184. Middle East and Africa Bifidobacterium Animalis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Bifidobacterium Animalis Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Bifidobacterium Animalis Distributors List Table 189. Bifidobacterium Animalis Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Bifidobacterium Animalis Image Figure 2. Global Bifidobacterium Animalis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bifidobacterium Animalis Market Size (2021-2032) & (US$ Million) Figure 4. Global Bifidobacterium Animalis Sales (2021-2032) & (t) Figure 5. Bifidobacterium Animalis Subsp. Lactis Image Figure 6. Global Bifidobacterium Animalis Subsp. Lactis Sales YoY Growth (2021-2032) & (t) Figure 7. Bifidobacterium Animalis Subsp. Image Figure 8. Global Bifidobacterium Animalis Subsp. Sales YoY Growth (2021-2032) & (t) Figure 9. Global Bifidobacterium Animalis Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Bifidobacterium Animalis Market Share by Type 2025 VS 2032 Figure 11. North America Bifidobacterium Animalis Sales Market Share in Volume by Type in 2025 Figure 12. North America Bifidobacterium Animalis Sales Market Share in Value by Type in 2025 Figure 13. Europe Bifidobacterium Animalis Sales Market Share in Volume by Type in 2025 Figure 14. Europe Bifidobacterium Animalis Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Bifidobacterium Animalis Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Bifidobacterium Animalis Sales Market Share in Value by Type in 2025 Figure 17. Latin America Bifidobacterium Animalis Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Bifidobacterium Animalis Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Bifidobacterium Animalis Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Bifidobacterium Animalis Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Bifidobacterium Animalis Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Medicine and Health Products Image Figure 24. Global Medicine and Health Products Sales YoY Growth (2021-2032) & (t) Figure 25. Food Image Figure 26. Global Food Sales YoY Growth (2021-2032) & (t) Figure 27. Clinical Auxiliary Treatment Image Figure 28. Global Clinical Auxiliary Treatment Sales YoY Growth (2021-2032) & (t) Figure 29. Animal Feed Image Figure 30. Global Animal Feed Sales YoY Growth (2021-2032) & (t) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (t) Figure 33. Global Bifidobacterium Animalis Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Bifidobacterium Animalis Market Share by Application 2025 VS 2032 Figure 35. North America Bifidobacterium Animalis Sales Market Share in Volume by Application in 2025 Figure 36. North America Bifidobacterium Animalis Sales Market Share in Value by Application in 2025 Figure 37. Europe Bifidobacterium Animalis Sales Market Share in Volume by Application in 2025 Figure 38. Europe Bifidobacterium Animalis Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Bifidobacterium Animalis Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Bifidobacterium Animalis Sales Market Share in Value by Application in 2025 Figure 41. Latin America Bifidobacterium Animalis Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Bifidobacterium Animalis Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Bifidobacterium Animalis Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Bifidobacterium Animalis Sales Market Share in Value by Application in 2025 Figure 45. North America Bifidobacterium Animalis Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 46. North America Bifidobacterium Animalis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Bifidobacterium Animalis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Bifidobacterium Animalis Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Bifidobacterium Animalis Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. Europe Bifidobacterium Animalis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Bifidobacterium Animalis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Bifidobacterium Animalis Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Bifidobacterium Animalis Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Asia-Pacific Bifidobacterium Animalis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Bifidobacterium Animalis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Bifidobacterium Animalis Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Bifidobacterium Animalis Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Latin America Bifidobacterium Animalis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Bifidobacterium Animalis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Bifidobacterium Animalis Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Bifidobacterium Animalis Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 62. Middle East and Africa Bifidobacterium Animalis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Bifidobacterium Animalis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Bifidobacterium Animalis Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Bifidobacterium Animalis Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Bifidobacterium Animalis Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Bifidobacterium Animalis Subsp. Lactis
  • Bifidobacterium Animalis Subsp.
Applications
  • Medicine and Health Products
  • Food
  • Clinical Auxiliary Treatment
  • Animal Feed
  • Other
Companies covered
  • ADM
  • ATCC
  • Chr. Hansen
  • Creative Biolabs
  • DuPont Nutrition & Biosciences
  • Fengchen Group
  • Microbiologics
  • Morinaga
  • SynBalance
  • BGI Nutri
  • Wecare Probiotics
  • Yili Group
  • Wisbiom (Beijing) Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bifidobacterium Animalis Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bifidobacterium Animalis Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bifidobacterium Animalis Market by Type
  6. 1.3.1 Bifidobacterium Animalis Subsp. Lactis
  7. 1.3.2 Bifidobacterium Animalis Subsp.
  8. 1.4 Global Bifidobacterium Animalis Market Size by Type
  9. 1.4.1 Global Bifidobacterium Animalis Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Bifidobacterium Animalis Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Bifidobacterium Animalis Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Bifidobacterium Animalis Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Bifidobacterium Animalis Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Bifidobacterium Animalis Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Bifidobacterium Animalis Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Bifidobacterium Animalis Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bifidobacterium Animalis Industry Trends
  2. 2.2 Bifidobacterium Animalis Industry Drivers
  3. 2.3 Bifidobacterium Animalis Industry Opportunities and Challenges
  4. 2.4 Bifidobacterium Animalis Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bifidobacterium Animalis Revenue (2021-2026)
  2. 3.2 Global Top Players by Bifidobacterium Animalis Sales (2021-2026)
  3. 3.3 Global Top Players by Bifidobacterium Animalis Price (2021-2026)
  4. 3.4 Global Bifidobacterium Animalis Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bifidobacterium Animalis Major Company Production Sites & Headquarters
  6. 3.6 Global Bifidobacterium Animalis Company, Product Type & Application
  7. 3.7 Global Bifidobacterium Animalis Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bifidobacterium Animalis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bifidobacterium Animalis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bifidobacterium Animalis Tier 1, Tier 2, and Tier 3
4 Bifidobacterium Animalis Regional Status and Outlook
  1. 4.1 Global Bifidobacterium Animalis Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bifidobacterium Animalis Historic Market Size by Region
  3. 4.2.1 Global Bifidobacterium Animalis Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bifidobacterium Animalis Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bifidobacterium Animalis Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bifidobacterium Animalis Forecasted Market Size by Region
  7. 4.3.1 Global Bifidobacterium Animalis Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bifidobacterium Animalis Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bifidobacterium Animalis Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bifidobacterium Animalis by Application
  1. 5.1 Bifidobacterium Animalis Market by Application
  2. 5.1.1 Medicine and Health Products
  3. 5.1.2 Food
  4. 5.1.3 Clinical Auxiliary Treatment
  5. 5.1.4 Animal Feed
  6. 5.1.5 Other
  7. 5.2 Global Bifidobacterium Animalis Market Size by Application
  8. 5.2.1 Global Bifidobacterium Animalis Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Bifidobacterium Animalis Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Bifidobacterium Animalis Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Bifidobacterium Animalis Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Bifidobacterium Animalis Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Bifidobacterium Animalis Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Bifidobacterium Animalis Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Bifidobacterium Animalis Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ADM
  2. 6.1.1 ADM Company Information
  3. 6.1.2 ADM Business Overview
  4. 6.1.3 ADM Bifidobacterium Animalis Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ADM Bifidobacterium Animalis Product Portfolio
  6. 6.1.5 ADM Recent Developments
  7. 6.2 ATCC
  8. 6.2.1 ATCC Company Information
  9. 6.2.2 ATCC Business Overview
  10. 6.2.3 ATCC Bifidobacterium Animalis Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ATCC Bifidobacterium Animalis Product Portfolio
  12. 6.2.5 ATCC Recent Developments
  13. 6.3 Chr. Hansen
  14. 6.3.1 Chr. Hansen Company Information
  15. 6.3.2 Chr. Hansen Business Overview
  16. 6.3.3 Chr. Hansen Bifidobacterium Animalis Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chr. Hansen Bifidobacterium Animalis Product Portfolio
  18. 6.3.5 Chr. Hansen Recent Developments
  19. 6.4 Creative Biolabs
  20. 6.4.1 Creative Biolabs Company Information
  21. 6.4.2 Creative Biolabs Business Overview
  22. 6.4.3 Creative Biolabs Bifidobacterium Animalis Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Creative Biolabs Bifidobacterium Animalis Product Portfolio
  24. 6.4.5 Creative Biolabs Recent Developments
  25. 6.5 DuPont Nutrition & Biosciences
  26. 6.5.1 DuPont Nutrition & Biosciences Company Information
  27. 6.5.2 DuPont Nutrition & Biosciences Business Overview
  28. 6.5.3 DuPont Nutrition & Biosciences Bifidobacterium Animalis Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 DuPont Nutrition & Biosciences Bifidobacterium Animalis Product Portfolio
  30. 6.5.5 DuPont Nutrition & Biosciences Recent Developments
  31. 6.6 Fengchen Group
  32. 6.6.1 Fengchen Group Company Information
  33. 6.6.2 Fengchen Group Business Overview
  34. 6.6.3 Fengchen Group Bifidobacterium Animalis Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fengchen Group Bifidobacterium Animalis Product Portfolio
  36. 6.6.5 Fengchen Group Recent Developments
  37. 6.7 Microbiologics
  38. 6.7.1 Microbiologics Company Information
  39. 6.7.2 Microbiologics Business Overview
  40. 6.7.3 Microbiologics Bifidobacterium Animalis Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Microbiologics Bifidobacterium Animalis Product Portfolio
  42. 6.7.5 Microbiologics Recent Developments
  43. 6.8 Morinaga
  44. 6.8.1 Morinaga Company Information
  45. 6.8.2 Morinaga Business Overview
  46. 6.8.3 Morinaga Bifidobacterium Animalis Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Morinaga Bifidobacterium Animalis Product Portfolio
  48. 6.8.5 Morinaga Recent Developments
  49. 6.9 SynBalance
  50. 6.9.1 SynBalance Company Information
  51. 6.9.2 SynBalance Business Overview
  52. 6.9.3 SynBalance Bifidobacterium Animalis Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 SynBalance Bifidobacterium Animalis Product Portfolio
  54. 6.9.5 SynBalance Recent Developments
  55. 6.10 BGI Nutri
  56. 6.10.1 BGI Nutri Company Information
  57. 6.10.2 BGI Nutri Business Overview
  58. 6.10.3 BGI Nutri Bifidobacterium Animalis Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 BGI Nutri Bifidobacterium Animalis Product Portfolio
  60. 6.10.5 BGI Nutri Recent Developments
  61. 6.11 Wecare Probiotics
  62. 6.11.1 Wecare Probiotics Company Information
  63. 6.11.2 Wecare Probiotics Business Overview
  64. 6.11.3 Wecare Probiotics Bifidobacterium Animalis Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Wecare Probiotics Bifidobacterium Animalis Product Portfolio
  66. 6.11.5 Wecare Probiotics Recent Developments
  67. 6.12 Yili Group
  68. 6.12.1 Yili Group Company Information
  69. 6.12.2 Yili Group Business Overview
  70. 6.12.3 Yili Group Bifidobacterium Animalis Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Yili Group Bifidobacterium Animalis Product Portfolio
  72. 6.12.5 Yili Group Recent Developments
  73. 6.13 Wisbiom (Beijing) Biotechnology
  74. 6.13.1 Wisbiom (Beijing) Biotechnology Company Information
  75. 6.13.2 Wisbiom (Beijing) Biotechnology Business Overview
  76. 6.13.3 Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Product Portfolio
  78. 6.13.5 Wisbiom (Beijing) Biotechnology Recent Developments
7 North America by Country
  1. 7.1 North America Bifidobacterium Animalis Sales by Country
  2. 7.1.1 North America Bifidobacterium Animalis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bifidobacterium Animalis Sales by Country (2021-2026)
  4. 7.1.3 North America Bifidobacterium Animalis Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bifidobacterium Animalis Market Size by Country
  6. 7.2.1 North America Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bifidobacterium Animalis Market Size by Country (2021-2026)
  8. 7.2.3 North America Bifidobacterium Animalis Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bifidobacterium Animalis Sales by Country
  2. 8.1.1 Europe Bifidobacterium Animalis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bifidobacterium Animalis Sales by Country (2021-2026)
  4. 8.1.3 Europe Bifidobacterium Animalis Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bifidobacterium Animalis Market Size by Country
  6. 8.2.1 Europe Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bifidobacterium Animalis Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bifidobacterium Animalis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bifidobacterium Animalis Sales by Country
  2. 9.1.1 Asia-Pacific Bifidobacterium Animalis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bifidobacterium Animalis Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bifidobacterium Animalis Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bifidobacterium Animalis Market Size by Country
  6. 9.2.1 Asia-Pacific Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bifidobacterium Animalis Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bifidobacterium Animalis Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bifidobacterium Animalis Sales by Country
  2. 10.1.1 South America Bifidobacterium Animalis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bifidobacterium Animalis Sales by Country (2021-2026)
  4. 10.1.3 South America Bifidobacterium Animalis Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bifidobacterium Animalis Market Size by Country
  6. 10.2.1 South America Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bifidobacterium Animalis Market Size by Country (2021-2026)
  8. 10.2.3 South America Bifidobacterium Animalis Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bifidobacterium Animalis Sales by Country
  2. 11.1.1 Middle East and Africa Bifidobacterium Animalis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bifidobacterium Animalis Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bifidobacterium Animalis Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bifidobacterium Animalis Market Size by Country
  6. 11.2.1 Middle East and Africa Bifidobacterium Animalis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bifidobacterium Animalis Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bifidobacterium Animalis Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bifidobacterium Animalis Value Chain Analysis
  2. 12.1.1 Bifidobacterium Animalis Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bifidobacterium Animalis Production Mode & Process
  7. 12.2 Bifidobacterium Animalis Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bifidobacterium Animalis Distributors
  10. 12.2.3 Bifidobacterium Animalis Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst